¡Protection against exacerbations and the risk of mortality!
Welcome to our Chronic Obstructive Pulmonary Disease section
In this space you will find a wide variety of support materials for you and your patients with COPD
Continuous Medical Education
Breztri Clinical Evidence
Speaker: Dr. Mark Cohen
Dr. Cohen explains the criteria and clinical results of the ETHOS and KRONOS studies.
COPD - Breztri Launch
Speaker: Pr. Terence Seemungal
Prof. Seemungal exposes the context of COPD in the Caribbean Countries as well as the implications of the disease in the patient and the associated cardiopulmonary risk.
COPD - Exacerbation and Mortality
Speaker: Pr. Terence Seemungal
Prof. Terence Seemungal examines the impact of COPD exacerbations on patient mortality, emphasizing the importance of timely treatment interventions to improve clinical outcomes.
COPD - Spirometry and other differential diagnostic tools
Speaker: Dr. Paul Scott
Dr. Paul Scott discusses the use of spirometry and additional differential diagnostic tools in the evaluation of COPD, emphasizing their importance in accurately diagnosing the condition and distinguishing it from other respiratory diseases.
COPD - Pathophysiology and its Cardiopulmonary Risk
Speaker: Dr. Althea Aquart-Stewart
Dr. Althea Aquart-Stewart explores the pathophysiology of COPD and highlights the associated cardiopulmonary risks, providing insight into the underlying mechanisms that impact patient health.
Supporting Materials for Doctors
Supporting Material for Patients
How to use your inhaler
Find the step by step of using the inhaler for the first triple therapy available for COPD.
Comprehensive Asthma Approach
Below, you will find the different areas covered by our Respiratory line, in addition to campaigns and events organized by AstraZeneca Central America and the Caribbean.
Made by AstraZeneca CAMCAR Costa Rica S.A. Roble Corporate Center, 5th floor, Escazú, San José, Costa Rica, telephone: (506) 2201 3400, postal box: 993-1260 Escazú. www.camcar.astrazeneca.com for AstraZeneca CAMCAR S.A. To report an adverse effect send an email to CAMCAR.Patientsafety@astrazeneca.com